OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Racial/Ethnic Disparities in Breast Cancer Incidence, Risk Factors, Health Care Utilization, and Outcomes in the USA
Annina Seiler, Kyle W. Murdock, Luz M. Garcini, et al.
Current Breast Cancer Reports (2017) Vol. 9, Iss. 2, pp. 91-99
Closed Access | Times Cited: 11
Annina Seiler, Kyle W. Murdock, Luz M. Garcini, et al.
Current Breast Cancer Reports (2017) Vol. 9, Iss. 2, pp. 91-99
Closed Access | Times Cited: 11
Showing 11 citing articles:
eHealth and mHealth interventions in the treatment of fatigued cancer survivors: A systematic review and meta-analysis
Annina Seiler, Vanessa Klaas, Gerhard Tröster, et al.
Psycho-Oncology (2017) Vol. 26, Iss. 9, pp. 1239-1253
Closed Access | Times Cited: 169
Annina Seiler, Vanessa Klaas, Gerhard Tröster, et al.
Psycho-Oncology (2017) Vol. 26, Iss. 9, pp. 1239-1253
Closed Access | Times Cited: 169
Functional connectome biotypes of chemotherapy-related cognitive impairment
Shelli R. Kesler, Melissa Petersen, Vikram Rao, et al.
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 4, pp. 483-493
Open Access | Times Cited: 37
Shelli R. Kesler, Melissa Petersen, Vikram Rao, et al.
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 4, pp. 483-493
Open Access | Times Cited: 37
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens
Ming Dai, Feng Yin, Shang Wen Chen, et al.
Breast Cancer Research and Treatment (2021) Vol. 189, Iss. 3, pp. 665-676
Open Access | Times Cited: 19
Ming Dai, Feng Yin, Shang Wen Chen, et al.
Breast Cancer Research and Treatment (2021) Vol. 189, Iss. 3, pp. 665-676
Open Access | Times Cited: 19
The impact of intimate partner violence on breast and cervical cancer survivors in an integrated, safety-net setting
Katelyn K. Jetelina, Christian Carr, Caitlin C. Murphy, et al.
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 6, pp. 906-914
Open Access | Times Cited: 17
Katelyn K. Jetelina, Christian Carr, Caitlin C. Murphy, et al.
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 6, pp. 906-914
Open Access | Times Cited: 17
Comparative Analysis of Breast Cancer Incidence Rates between Australia and Japan: Screening Target Implications
Miwa Mia Mizukoshi, Syeda Zakia Hossian, Ann Poulos
Asian Pacific Journal of Cancer Prevention (2020) Vol. 21, Iss. 7, pp. 2123-2129
Open Access | Times Cited: 17
Miwa Mia Mizukoshi, Syeda Zakia Hossian, Ann Poulos
Asian Pacific Journal of Cancer Prevention (2020) Vol. 21, Iss. 7, pp. 2123-2129
Open Access | Times Cited: 17
Experiences and lessons learned from community-engaged recruitment for the South Asian breast cancer study in New Jersey during the COVID-19 pandemic
Jaya M. Satagopan, Tina Dharamdasani, Shailja Mathur, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294170-e0294170
Open Access | Times Cited: 5
Jaya M. Satagopan, Tina Dharamdasani, Shailja Mathur, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294170-e0294170
Open Access | Times Cited: 5
A Multimetric Evaluation of Online Spanish Health Resources for Lymphedema
Anna Rose Johnson, Andres F. Doval, Sabine A. Egeler, et al.
Annals of Plastic Surgery (2019) Vol. 82, Iss. 3, pp. 255-261
Closed Access | Times Cited: 14
Anna Rose Johnson, Andres F. Doval, Sabine A. Egeler, et al.
Annals of Plastic Surgery (2019) Vol. 82, Iss. 3, pp. 255-261
Closed Access | Times Cited: 14
Black and Minority Ethnic women's decision-making for risk reduction strategies after BRCA testing: Use of context and knowledge
Mavis Machirori, Christine Patch, Alison Metcalfe
European Journal of Medical Genetics (2018) Vol. 62, Iss. 5, pp. 376-384
Open Access | Times Cited: 9
Mavis Machirori, Christine Patch, Alison Metcalfe
European Journal of Medical Genetics (2018) Vol. 62, Iss. 5, pp. 376-384
Open Access | Times Cited: 9
Recruiting and Retaining Patients with Breast Cancer in Exercise Trials: A Meta-analysis
Jeffrey C. Hoover, Aqeel M. Alenazi, Mohammed M. Alshehri, et al.
Translational Journal of the American College of Sports Medicine (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 3
Jeffrey C. Hoover, Aqeel M. Alenazi, Mohammed M. Alshehri, et al.
Translational Journal of the American College of Sports Medicine (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 3
Identifying county-level factors for female breast cancer incidence rate through a large-scale population study
Tingting Zhao, Zihan Cui, Mary McClellan, et al.
Applied Geography (2020) Vol. 125, pp. 102324-102324
Open Access | Times Cited: 1
Tingting Zhao, Zihan Cui, Mary McClellan, et al.
Applied Geography (2020) Vol. 125, pp. 102324-102324
Open Access | Times Cited: 1
Analysis of the Pan-Asian Subgroup of patients in the NALA Trial: A Randomized Phase III NALA Trial Comparing Neratinib + Capecitabine (N+C) vs Lapatinib + Capecitabine (L+C) in Patients with HER2+ Metastatic Breast Cancer (mBC) Previously Treated with Two or more HER2-Directed Regimens
Ming-Shen Dai, Feng Yin, Shang Wen Chen, et al.
Research Square (Research Square) (2021)
Open Access
Ming-Shen Dai, Feng Yin, Shang Wen Chen, et al.
Research Square (Research Square) (2021)
Open Access
